Evidence map›Paper›PMID 34754197›Full record

ArticleOncoTargets and therapy2021

Long-Term Survival After Salvage Thoracic Surgery on a Patient with

Kangqi Ren, Guanggui Ding, Shuying Xie, Lin Yang

Open access · goldAbstract readCase Reports
In one paragraph

Article in OncoTargets and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Coexistence of a novelFrontiers in oncology · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kangqi Ren *Department of Thoracic Surgery, Shenzhen People's Hospital & The Second Clinical Medical College of Jinan University, Shenzhen, People's Republic of China.
Guanggui Ding *Department of Thoracic Surgery, Shenzhen People's Hospital & The Second Clinical Medical College of Jinan University, Shenzhen, People's Republic of China.
Shuying XieDepartment of Medicine, Burning Rock Biotech, Guangzhou, People's Republic of China.ORCID 0000-0002-3986-2746
Lin YangDepartment of Thoracic Surgery, Shenzhen People's Hospital & The Second Clinical Medical College of Jinan University, Shenzhen, People's Republic of China.ORCID 0000-0003-0507-3068
ShenZhen People’s Hospital · CNBurning Rock Biotech (China) · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Targeted therapy for patients with advanced non-small cell lung cancer (NSCLC) is often challenged by the arising of drug resistance. After progression to targeted therapy, treatment options include continued targeted therapy, definitive local therapy, and the combination of both. While there is evidence that local ablative radiotherapy may prolong the disease control by targeted therapy, little is known regarding the relevance of salvage thoracic surgery in this setting. Herein, we presented a case of stage IV lung adenocarcinoma with concurrent

Indexed as

advanced non-small cell lung cancerALK F1174C mutationcrizotinibmultidisciplinary treatmentsalvage thoracic surgery

Identifiers

PMID34754197
PMCPMC8572106
OpenAlexW3208924813

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.